Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001137439-25-000157·AEON Biopharma, Inc.
Schedule 13G ownership disclosure
AEON BIOPHARMA INC
Common · CUSIP: 00791X209
Event date: 2025-02-26
- Filing-level shares
- 108,224.00
- Percent of class
- 9.7%
- Dauntless Investment Group, LLC
Shares: 108,224.00 · Class: 9.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001137439-25-000157
- Form type
- SCHEDULE 13G
- Filer
- AEON Biopharma, Inc.
- CIK
- CIK 1837607
- Filed
- Mar 03, 2025
- Reporting period
- Feb 26, 2025
- Description
- Schedule 13G beneficial ownership